Union Avenue Compounding Pharm is categorized under in Tacoma, WA and active since 1980.
Union Avenue Compounding Pharm was established in 1980, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a business, which does work in the B2C market, and is classified as a , under code number 4461100 by the NAICS.
If you are seeking more information, feel free to contact Kim Burkes, Owner at the company’s single location by writing to 2302 South Union Avenue # C25, Tacoma, Washington WA 98405 or by phoning (253) 752-1705. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Union Avenue Compounding Pharm |
| Contact Person: | Kim Burkes, Owner |
| Address: | 2302 South Union Avenue # C25, Tacoma, Washington 98405 |
| Phone Number: | (253) 752-1705 |
| Website Address: | unionavenuerx.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 1980 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | |
| SIC Code: | 5912 |
| NAICS Code: | 4461100 |
| Share This Business: |
Union Avenue Compounding Pharm was started in 1980 to provide professional under the SIC code 5912 and NAICS code 4461100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Kim Burkes, Owner for inquiries that concern Union Avenue Compounding Pharm by calling the company number (253) 752-1705, as your correspondence is most welcome. Additionally, the physical location of the single location of Union Avenue Compounding Pharm can be found at the coordinates 47.238748,-122.481926 as well as the street address 2302 South Union Avenue # C25 in Tacoma, Washington 98405.
For its online presence, you may visit Union Avenue Compounding Pharm’s website at unionavenuerx.com and engage with its social media outlets through on Twitter and on Facebook.